Clinical Trial Update: The Topical Niacin Skin Flush Test in First Episode Psychosis

View source ↗

Summary

A clinical trial evaluating a topical niacin skin flush test for first-episode psychosis and schizophrenia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Niacin (nicotinic acid)

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Psychotic Disorders, Schizophrenia | Status: TERMINATED